Recommended

Teva close to API business sale
Streamlined rAAV purification enables efficient upstream analytics – access now
First new IPF treatment in US for a decade
Webinar: Radiopharmaceuticals’ time-to-result challenge
AstraZeneca/Daiichi cancer drug boost
Takeda to move away from cell therapy
GSK appoints new CEO
article

Expert view: Enabling Pharma 4.0 through digital transformation

1
SHARES

Posted: 26 October 2020 | | No comments yet

Digital transformation refers to the advent of various new and advancing technologies and their application in business to drive organisational efficiencies that would otherwise be impossible to achieve.

Join our free webinar: The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology

Join this webinar to find out how RT-rt PCR is revolutionising sterility testing and discover a unique approach that provides reliable one-day results and enhanced sensitivity and detection capabilities.

Date: 5 Nov | Time: 15:00 BST

REGISTER NOW TO SECURE YOUR SPOT <<<

Can’t attend live? No worries – register to receive the recording post-event.

 

 

Reserve your FREE place

 


Address the time-to-result challenge posed by short shelf-life radiopharmaceuticals.

20 November 2025 | 3:00 PM GMT | FREE Virtual Panel Discussion

This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.

Key learning points:

  • Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
  • Learn about ITM’s implementation journey and considerations when evaluating the technology
  • Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).

Don’t miss your chance to learn from experts in the industry – Register for FREE

 

As the world leader in serving science, Thermo Fisher Scientific Inc. (NYSE: TMO) is partnering with customers to connect the physical and the digital. Our state-ofthe-art laboratory data management solutions help our pharmaceutical and biopharmaceutical customers to accelerate their digital transformation by orchestrating their laboratory operations while addressing regulatory and business challenges.

The Thermo Scientific SampleManager LIMS software suite is a complete solution that includes LIMS (laboratory information management system), LES (lab execution system), ELN (electronic lab notebook) and SDMS (scientific data management system). Half of the world’s top 10 pharmaceutical companies as well as Thermo Fisher Scientific’s pharma services business rely on SampleManager LIMS software to streamline operations ensuring consistency, efficiency and productivity across their manufacturing QA/QC laboratories.

Connecting quality data from the manufacturing plant and the laboratory gives organisations a holistic view enabling them to execute on their Pharma 4.0 strategy. Through integrated, end-to-end workflows, organisations are able to monitor data in real time and adopt a truly agile manufacturing process which self-adjusts to ensure the quality of their drug product.

Organisations need to adopt the technology, people and process changes needed to align their business to the Pharma 4.0 model. Achieving a smart factory requires a smart laboratory and connected information systems. Digital transformation is the key to achieving Pharma 4.0 and Thermo Fisher Scientific is uniquely positioned to support pharmaceutical organisations through this journey.

Share via
Share via